vs

Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and Smart Sand, Inc. (SND). Click either name above to swap in a different company.

Smart Sand, Inc. is the larger business by last-quarter revenue ($86.0M vs $47.7M, roughly 1.8× IRONWOOD PHARMACEUTICALS INC). Smart Sand, Inc. runs the higher net margin — 1.4% vs -4.8%, a 6.1% gap on every dollar of revenue. On growth, Smart Sand, Inc. posted the faster year-over-year revenue change (-5.8% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $20.4M). Over the past eight quarters, Smart Sand, Inc.'s revenue compounded faster (1.8% CAGR vs -20.2%).

Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.

Sand 9 is a fabless Micro-electromechanical system (MEMS) company based in Cambridge, Massachusetts. Sand 9 developed a piezoelectric MEMS resonator to serve as an alternative for quartz timing devices in applications such as smart phones, low-power wireless devices, and communications infrastructure equipment.

IRWD vs SND — Head-to-Head

Bigger by revenue
SND
SND
1.8× larger
SND
$86.0M
$47.7M
IRWD
Growing faster (revenue YoY)
SND
SND
+41.5% gap
SND
-5.8%
-47.3%
IRWD
Higher net margin
SND
SND
6.1% more per $
SND
1.4%
-4.8%
IRWD
More free cash flow
IRWD
IRWD
$54.2M more FCF
IRWD
$74.6M
$20.4M
SND
Faster 2-yr revenue CAGR
SND
SND
Annualised
SND
1.8%
-20.2%
IRWD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IRWD
IRWD
SND
SND
Revenue
$47.7M
$86.0M
Net Profit
$-2.3M
$1.2M
Gross Margin
13.0%
Operating Margin
14.3%
-3.1%
Net Margin
-4.8%
1.4%
Revenue YoY
-47.3%
-5.8%
Net Profit YoY
-200.9%
-68.5%
EPS (diluted)
$0.01
$0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRWD
IRWD
SND
SND
Q4 25
$47.7M
$86.0M
Q3 25
$122.1M
$92.8M
Q2 25
$85.2M
$85.8M
Q1 25
$41.1M
$65.6M
Q4 24
$90.5M
$91.4M
Q3 24
$91.6M
$63.2M
Q2 24
$94.4M
$73.8M
Q1 24
$74.9M
$83.1M
Net Profit
IRWD
IRWD
SND
SND
Q4 25
$-2.3M
$1.2M
Q3 25
$40.1M
$3.0M
Q2 25
$23.6M
$21.4M
Q1 25
$-37.4M
$-24.2M
Q4 24
$2.3M
$3.7M
Q3 24
$3.6M
$-98.0K
Q2 24
$-860.0K
$-430.0K
Q1 24
$-4.2M
$-216.0K
Gross Margin
IRWD
IRWD
SND
SND
Q4 25
13.0%
Q3 25
16.1%
Q2 25
10.4%
Q1 25
4.2%
Q4 24
14.7%
Q3 24
10.3%
Q2 24
17.7%
Q1 24
14.2%
Operating Margin
IRWD
IRWD
SND
SND
Q4 25
14.3%
-3.1%
Q3 25
61.8%
5.8%
Q2 25
53.2%
-0.1%
Q1 25
-70.7%
-10.8%
Q4 24
34.8%
3.9%
Q3 24
28.0%
-7.8%
Q2 24
26.5%
4.8%
Q1 24
14.7%
0.9%
Net Margin
IRWD
IRWD
SND
SND
Q4 25
-4.8%
1.4%
Q3 25
32.8%
3.2%
Q2 25
27.7%
24.9%
Q1 25
-90.9%
-37.0%
Q4 24
2.5%
4.1%
Q3 24
4.0%
-0.2%
Q2 24
-0.9%
-0.6%
Q1 24
-5.6%
-0.3%
EPS (diluted)
IRWD
IRWD
SND
SND
Q4 25
$0.01
$0.03
Q3 25
$0.23
$0.08
Q2 25
$0.14
$0.54
Q1 25
$-0.23
$-0.62
Q4 24
$0.03
$0.10
Q3 24
$0.02
$0.00
Q2 24
$-0.01
$-0.01
Q1 24
$-0.03
$-0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRWD
IRWD
SND
SND
Cash + ST InvestmentsLiquidity on hand
$215.5M
$22.6M
Total DebtLower is stronger
$15.0M
Stockholders' EquityBook value
$-261.8M
$239.7M
Total Assets
$396.9M
$340.0M
Debt / EquityLower = less leverage
0.06×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRWD
IRWD
SND
SND
Q4 25
$215.5M
$22.6M
Q3 25
$140.4M
$5.1M
Q2 25
$92.9M
$4.3M
Q1 25
$108.5M
$5.1M
Q4 24
$88.6M
$1.6M
Q3 24
$88.2M
$7.2M
Q2 24
$105.5M
$6.3M
Q1 24
$121.5M
$4.6M
Total Debt
IRWD
IRWD
SND
SND
Q4 25
$15.0M
Q3 25
$199.5M
$14.3M
Q2 25
$199.3M
$23.5M
Q1 25
$199.2M
$13.7M
Q4 24
$199.0M
$14.7M
Q3 24
$198.8M
$15.7M
Q2 24
$198.6M
$17.1M
Q1 24
$398.3M
$25.5M
Stockholders' Equity
IRWD
IRWD
SND
SND
Q4 25
$-261.8M
$239.7M
Q3 25
$-264.2M
$239.9M
Q2 25
$-308.2M
$240.5M
Q1 25
$-334.1M
$219.9M
Q4 24
$-301.3M
$243.8M
Q3 24
$-311.3M
$243.6M
Q2 24
$-321.7M
$242.9M
Q1 24
$-330.5M
$242.5M
Total Assets
IRWD
IRWD
SND
SND
Q4 25
$396.9M
$340.0M
Q3 25
$396.1M
$343.1M
Q2 25
$342.9M
$345.8M
Q1 25
$327.2M
$326.9M
Q4 24
$350.9M
$341.5M
Q3 24
$389.5M
$335.8M
Q2 24
$395.6M
$341.8M
Q1 24
$438.8M
$349.3M
Debt / Equity
IRWD
IRWD
SND
SND
Q4 25
0.06×
Q3 25
0.06×
Q2 25
0.10×
Q1 25
0.06×
Q4 24
0.06×
Q3 24
0.06×
Q2 24
0.07×
Q1 24
0.11×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IRWD
IRWD
SND
SND
Operating Cash FlowLast quarter
$74.6M
$22.4M
Free Cash FlowOCF − Capex
$74.6M
$20.4M
FCF MarginFCF / Revenue
156.3%
23.7%
Capex IntensityCapex / Revenue
0.0%
2.3%
Cash ConversionOCF / Net Profit
18.99×
TTM Free Cash FlowTrailing 4 quarters
$127.0M
$32.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IRWD
IRWD
SND
SND
Q4 25
$74.6M
$22.4M
Q3 25
$47.6M
$18.2M
Q2 25
$-15.1M
$-5.1M
Q1 25
$20.0M
$8.7M
Q4 24
$15.2M
$1.0M
Q3 24
$9.9M
$5.8M
Q2 24
$33.5M
$14.9M
Q1 24
$45.0M
$-3.9M
Free Cash Flow
IRWD
IRWD
SND
SND
Q4 25
$74.6M
$20.4M
Q3 25
$47.6M
$14.8M
Q2 25
$-15.1M
$-7.8M
Q1 25
$19.9M
$5.2M
Q4 24
$-840.0K
Q3 24
$9.9M
$3.7M
Q2 24
$33.4M
$13.5M
Q1 24
$44.9M
$-5.5M
FCF Margin
IRWD
IRWD
SND
SND
Q4 25
156.3%
23.7%
Q3 25
39.0%
15.9%
Q2 25
-17.7%
-9.1%
Q1 25
48.4%
7.9%
Q4 24
-0.9%
Q3 24
10.8%
5.8%
Q2 24
35.4%
18.3%
Q1 24
60.0%
-6.6%
Capex Intensity
IRWD
IRWD
SND
SND
Q4 25
0.0%
2.3%
Q3 25
0.0%
3.6%
Q2 25
0.0%
3.1%
Q1 25
0.1%
5.4%
Q4 24
0.0%
2.1%
Q3 24
0.0%
3.4%
Q2 24
0.1%
1.8%
Q1 24
0.1%
2.0%
Cash Conversion
IRWD
IRWD
SND
SND
Q4 25
18.99×
Q3 25
1.19×
6.05×
Q2 25
-0.64×
-0.24×
Q1 25
Q4 24
6.74×
0.28×
Q3 24
2.71×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IRWD
IRWD

Segment breakdown not available.

SND
SND

Sand$85.1M99%
Smart Systems Segment$980.0K1%

Related Comparisons